Biotest Pharmaceuticals Corporation - From Nature for Life

On January 19, 2018, Biotest AG announced it had entered into an agreement for the sale of Biotest Pharmaceuticals Corporation (BPC). BPC is now owned and operated under a US trust until this sale closes.

Biotest AG, BPC’s former parent company, is now majority (90 percent) owned by Tiancheng (Germany) Pharmaceuticals Holdings AG, a subsidiary of CREAT, a company organized and existing under the laws of the People’s Republic of China.

Established in 2007, Biotest Pharmaceuticals owns and manages plasmapheresis centers across the United States. Biotest Pharmaceuticals employs more than 700 employees in the US.



Plasma for Further Manufacturing

Through the Company's quality systems and exceptional services, Biotest Pharmaceuticals takes pride in being one of the top global providers of source and specialty antibody plasma products.

more arrow

The information contained on this website is not intended to be a substitute for the advice of a health care professional, or a recommendation for any particular treatment plan. Medical information changes rapidly and it is important that consumers rely on the advice of a health care professional to employ good clinical judgment for the specific conditions of individual patients.